{"title":"Factors associated with peripheral neuropathy among patients with type 2 diabetes mellitus: A cross-sectional study","authors":"Pankaj Punjot, R. Bishnoi, Ravi Kant, S. Sharma","doi":"10.4103/JCDM.JCDM_6_20","DOIUrl":null,"url":null,"abstract":"Background: Diabetes mellitus (DM) is a major health problem globally. It is estimated that approximately 50% of people with diabetes suffer from diabetes peripheral neuropathy (DPN). All patients with diabetes should be screened for peripheral neuropathy. Therefore, this study was undertaken to explore and determine the factors associated with peripheral neuropathy. Materials and Methods: A cross-sectional study was conducted on patients with type 2 DM and with peripheral neuropathy at a patient visiting diabetes clinic of a tertiary care center. Neuropathy analysis was done by a peripheral neuropathy analyzer (Vibrotherm: EN ISO 13485:2012). The test consisted of four different steps: The first step was vibration perception for a six-point assessment of each foot; then, cold perception; hot perception; and finally, a 10g Semmes-Weinstein monofilament test. Descriptive and inferential statistics were used for data analysis. Result: Out of 50 patients, the maximum were male (70%); mean age was 55.80 ± 11.48 years; 50% were living in urban areas, 40% in rural areas, and 10% in semi-urban areas; 34% were farmers, 26% were doing jobs, 24% were housewives, and 16% were businessmen. The mean duration of type 2 DM was 8.34 ± 7.89 years, and HbA1c (glycated hemoglobin) was 9.47 ± 3.17. Overall, 44 patients had neuropathy; among them, 29 had only large fiber neuropathy, 42 had small fiber neuropathy, and 27 had both small and large fiber neuropathy. Large fiber neuropathy was found to be significantly associated with HbA1c level and the duration of DM, and mixed fiber neuropathy was found to be significantly associated with the age of the participants (P < 0.05). Conclusion: Peripheral neuropathy is very common in patients with type 2 DM; it is associated with age, level of HbA1c, and the duration of DM, so early action should be taken to mitigate its occurrence.","PeriodicalId":196256,"journal":{"name":"Journal of Cardio-diabetes and metabolic disorders","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardio-diabetes and metabolic disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/JCDM.JCDM_6_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Background: Diabetes mellitus (DM) is a major health problem globally. It is estimated that approximately 50% of people with diabetes suffer from diabetes peripheral neuropathy (DPN). All patients with diabetes should be screened for peripheral neuropathy. Therefore, this study was undertaken to explore and determine the factors associated with peripheral neuropathy. Materials and Methods: A cross-sectional study was conducted on patients with type 2 DM and with peripheral neuropathy at a patient visiting diabetes clinic of a tertiary care center. Neuropathy analysis was done by a peripheral neuropathy analyzer (Vibrotherm: EN ISO 13485:2012). The test consisted of four different steps: The first step was vibration perception for a six-point assessment of each foot; then, cold perception; hot perception; and finally, a 10g Semmes-Weinstein monofilament test. Descriptive and inferential statistics were used for data analysis. Result: Out of 50 patients, the maximum were male (70%); mean age was 55.80 ± 11.48 years; 50% were living in urban areas, 40% in rural areas, and 10% in semi-urban areas; 34% were farmers, 26% were doing jobs, 24% were housewives, and 16% were businessmen. The mean duration of type 2 DM was 8.34 ± 7.89 years, and HbA1c (glycated hemoglobin) was 9.47 ± 3.17. Overall, 44 patients had neuropathy; among them, 29 had only large fiber neuropathy, 42 had small fiber neuropathy, and 27 had both small and large fiber neuropathy. Large fiber neuropathy was found to be significantly associated with HbA1c level and the duration of DM, and mixed fiber neuropathy was found to be significantly associated with the age of the participants (P < 0.05). Conclusion: Peripheral neuropathy is very common in patients with type 2 DM; it is associated with age, level of HbA1c, and the duration of DM, so early action should be taken to mitigate its occurrence.
背景:糖尿病(DM)是全球性的主要健康问题。据估计,大约50%的糖尿病患者患有糖尿病周围神经病变(DPN)。所有糖尿病患者都应进行周围神经病变筛查。因此,本研究旨在探讨和确定与周围神经病变相关的因素。材料和方法:对在三级保健中心糖尿病门诊就诊的2型糖尿病和周围神经病变患者进行横断面研究。神经病变分析由周围神经病变分析仪(Vibrotherm: EN ISO 13485:2012)完成。测试包括四个不同的步骤:第一步是振动感知,对每只脚进行六点评估;然后,冷感知;热的感觉;最后是10g Semmes-Weinstein单丝测试。采用描述性统计和推断性统计进行数据分析。结果:50例患者中,男性最多(70%);平均年龄55.80±11.48岁;50%生活在城市地区,40%生活在农村地区,10%生活在半城市地区;34%是农民,26%是工人,24%是家庭主妇,16%是商人。2型糖尿病的平均病程为8.34±7.89年,糖化血红蛋白(HbA1c)为9.47±3.17年。总体而言,44例患者有神经病变;其中仅大纤维神经病29例,小纤维神经病42例,小纤维和大纤维兼有27例。大纤维神经病变与HbA1c水平及DM病程显著相关,混合纤维神经病变与受试者年龄显著相关(P < 0.05)。结论:周围神经病变在2型糖尿病患者中非常常见;糖尿病与年龄、糖化血红蛋白水平和糖尿病持续时间有关,因此应及早采取措施减轻糖尿病的发生。